Coronavirus Disease 2019 (COVID-19) and the Kidney – Biosampling as part of the BIOMASOTA-Biobank

Coronavirus Disease 2019 (COVID-19) and the Kidney – Biosampling as part of the BIOMASOTA-Biobank - COVID-19 in BioMaSoTa

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00024702

Enrollment

2500

Registered

2021-03-11

Start date

2020-08-20

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney diseases U07.1

Interventions

Group 1: Patients with clinical suspicion of SARS-CoV-2 infection will be asked for consent for using of residual samples (serum, urine, stool, saliva and tissue samples ) collected within the BioMaSo

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: clinical suspicion of COVID-19 infection

Exclusion criteria

Exclusion criteria: Lack of ability of consent, lack of concent to BioMaSOTA (Biobanking of Institute for Pathology, University of Cologne)

Design outcomes

Primary

Measure	Time frame
Biosampling (serum, urine, stool, saliva and tissue samples ) within the BioMaSoTa project of the Institute of Pathology of the University Hospital of Cologne in patients with clinical suspicion of SARS-CoV-2 infection to analyzed, whether there are the factors, which have an influence on the renal involvement in COVID-19, whether there are molecular biological factors, that predispose to renal involvement in COVID-19 infection (e.g. hematuria, proteinuria, acute renal injury).	—

Measure

Time frame

Biosampling (serum, urine, stool, saliva and tissue samples ) within the BioMaSoTa project of the Institute of Pathology of the University Hospital of Cologne in patients with clinical suspicion of SARS-CoV-2 infection to analyzed, whether there are the factors, which have an influence on the renal involvement in COVID-19, whether there are molecular biological factors, that predispose to renal involvement in COVID-19 infection (e.g. hematuria, proteinuria, acute renal injury).

—

Countries

Germany

Contacts

Public ContactRoman-Ulrich Müller

Klinik II für Innere Medizin Uniklinik Köln

roman-ulrich.mueller@uk-koeln.de+4922147886288

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026